World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
12272
World Ranking
3428
National Ranking
1592

Research.com Recognitions

  • 2019 - Distinguished Fellows of the American Association of Immunologists (AAI)

Overview

Linda A. Sherman is affiliated with the Scripps Research Institute in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Within these broader areas, their work includes significant contributions to Immunology, Molecular Biology, and Genetics.

The scientist's research topics focus on Protein Tyrosine Phosphatases, Diabetes and associated disorders, T-cell and B-cell Immunology, Atherosclerosis and Cardiovascular Diseases, Galectins and Cancer Biology, and interferon and immune responses.

Notable recent papers authored or co-authored by Sherman include:

  • "Proautoimmune Allele of Tyrosine Phosphatase, PTPN22, Enhances Tumor Immunity" (2021, The Journal of Immunology)
  • "Autoimmunity-associated allele of tyrosine phosphatase gene PTPN22 enhances anti-viral immunity" (2024, PLoS Pathogens)
  • "Pro-autoimmune allele of tyrosine phosphatase, PTPN22, enhances tumor immunity" (2021, bioRxiv [Cold Spring Harbor Laboratory])
  • "Wendy Havran 1955-2020" (2020, Nature Immunology)
  • "The Pro-autoimmune allele of tyrosine phosphatase PTPN22 enhances anti-viral and anti-tumor immunity" (2020, The Journal of Immunology)

The scientist frequently publishes in venues such as The Journal of Immunology, bioRxiv (Cold Spring Harbor Laboratory), PLoS Pathogens, and Nature Immunology.

Collaborative research has been conducted with frequent co-authors including:

  • Robin C. Orozco
  • Kristi Marquardt
  • Kerri Mowen
  • John R. Teijaro
  • Isaraphorn Pratumchai

Linda A. Sherman received the Distinguished Fellows of the American Association of Immunologists (AAI) award in 2019.

Best Publications

  • Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization.

    Fu-Tong Liu;J. W. Bohn;E. L. Ferry;H. Yamamoto

  • The Molecular Basis of Allorecognition

    L. A. Sherman;Suchismita Chattopadhyay

  • CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes.

    Rinke Bos;Linda A. Sherman

  • A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity.

    Kimberlyn F. Card;Shari A. Price-Schiavi;Bai Liu;Elizabeth Thomson

  • Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex.

    A Vitiello;D Marchesini;J Furze;L A Sherman

  • Targeting p53 as a general tumor antigen.

    Matthias Theobald;Judith Biggs;Dirk Dittmer;Arnold J. Levine

  • Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes

    Matthias Theobald;Judith Biggs;Javier Hernández;Joseph Lustgarten

  • Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy

    Tal Kafri;David Morgan;Troy Krahl;Nora E Sarvetnick

  • Peripheral tolerance of CD8 T lymphocytes.

    William L. Redmond;Linda A. Sherman

  • Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity.

    David J. Morgan;Huub T. C. Kreuwel;Shonna Fleck;Hyam I. Levitsky

  • CD8(+) T cell-mediated spontaneous diabetes in neonatal mice.

    David J. Morgan;Roland Liblau;Bernadette Scott;Shonna Fleck

  • Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen.

    Javier Hernandez;Sandra Aung;William L. Redmond;Linda A. Sherman

  • Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells

    David Lo;Jessica Freedman;Sabine Hesse;Richard D. Palmiter

  • The role of beta 2-microglobulin in peptide binding by class I molecules

    Antonella Vitiello;Terry A. Potter;Linda A. Sherman

  • Tumor Antigens are Constitutively Presented in the Draining Lymph Nodes

    Amanda L. Marzo;Richard A. Lake;David Lo;Linda Sherman

  • Antigen Concentration and Precursor Frequency Determine the Rate of CD8+ T Cell Tolerance to Peripherally Expressed Antigens

    David J. Morgan;Huub T. C. Kreuwel;Linda A. Sherman

  • Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.

    William R. Heath;Melissa E. Hurd;Francis R. Carbone;Linda A. Sherman

  • Cooperation of human tumor-reactive CD4 + and CD8 + T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR

    Jürgen Kuball;Frank W. Schmitz;Ralf Holger Voss;Edite Antunes Ferreira

  • Alloreactive T cells discriminate among a diverse set of endogenous peptides.

    William R. Heath;Kevin P. Kane;Matthew F. Mescher;Linda A. Sherman

  • Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response.

    M J Irwin;W R Heath;L A Sherman

Frequent Co-Authors

Norman R. Klinman
Norman R. Klinman Scripps Research Institute
Linda S. Wicker
Linda S. Wicker University of Oxford
William R. Heath
William R. Heath University of Melbourne
Matthew F. Mescher
Matthew F. Mescher University of Minnesota
Steven J. Burakoff
Steven J. Burakoff Icahn School of Medicine at Mount Sinai
David Lo
David Lo University of California, Riverside
Nora Sarvetnick
Nora Sarvetnick University of Nebraska Medical Center
Nunzio Bottini
Nunzio Bottini University of California, San Diego
Laurence B. Peterson
Laurence B. Peterson Roche (Switzerland)
Eric G. Pamer
Eric G. Pamer Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related nursing degrees can open many career doors. Transitioning into specialized roles often requires additional certifications, such as the fnp to acute care certification. This is ideal for family nurse practitioners aiming to focus on acute and critical care settings.

Accelerated pathways are popular for students who want to fast-track their nursing careers. The accelerated np program offers an efficient route to becoming a nurse practitioner, combining intensive coursework with practical experience. Similarly, many non-nurses can enter the field through online rn programs for non nurses, which provide a flexible option to earn registered nurse credentials without a traditional nursing background.

For those new to nursing who want to start quickly, accelerated nursing programs allow students to earn their Bachelor of Science in Nursing in a shorter time frame than conventional programs. These options increase accessibility and help meet the growing demand for skilled professionals in healthcare and immunology-related fields.

Best Scientists Citing Linda A. Sherman

Trending Scientists

Recently Published Articles